Vernix caseosa aspiration is an extremely rare condition resulting in high mortality if complicated by persistent hypertension of the newborn (PPHN). Herein we offer the first case report of PPHN due to massive vernix caseosa aspiration documented by histopathological examination. This case report is presented to provide a synopsis of the pathoetiology of PPHN related to vernix caseosa aspiration syndrome as likely to be encountered by neonatologists and general pediatricians involved with neonatal care.
HoathSBPickensWLVisscherMO. The biology of vernix caseosa. Int J Cosmetic Sci2006; 28: 319–333.
7.
UnderwoodMAGilbertWM. Amniotic fluid: not just fetal urine anymore. J Perinatol2005; 25: 341–348.
8.
FentonTR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr2003; 3: 13.
9.
van IerlandYde BeaufortAJ. Why does meconium cause meconium aspiration syndrome? Current concepts of MAS pathophysiology. Early Hum Dev2009; 85: 617–620.
10.
HolopainenRSoukkaHHalkolaL. Meconium aspiration induces a concentration-dependent pulmonary hypertensive response in newborn piglets. Pediatr Pulmonol1998; 25: 107–113.
11.
BanROgiharaTMoriY. Meconium aspiration delays normal decline of pulmonary vascular resistance shortly after birth through lung parenchymal injury. Neonatology2011; 99: 272–279.
12.
YigitSTekinalpGOranO. Endothelin 1 concentrations in infants with meconium stained amniotic fluid. Arch Dis Child Fetal Neonatal Ed2002; 87: F212–F213.
13.
HsiehTKSuBHChenACLinTWTsaiCHLinHC. Risk factors of meconium aspiration syndrome developing into persistent pulmonary hypertension of newborn. Acta Paediatr Taiwan2004; 45: 203–207.
14.
LevinDLHeymannMAHeymannMA. Fetal hypertension and the development of increased pulmonary vascular smooth muscle. A possible mechanism for persistent pulmonary hypertension of the newborn infant. J Pediatr1978; 92: 265–269.
15.
NakwanNPithaklimnuwongS. Acute kidney injury and pneumothorax are risk factors for mortality in persistent pulmonary hypertension of the newborn in Thai neonates. J Matern Fetal Neonatal Med2016; 29: 1741–1746.
16.
Walsh-SukysMCTysonJEWrightLL. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics2000; 105: 14–20.
17.
NakwanNNakwanNWannaroJ. Predicting mortality outcome in infants with persistent pulmonary hypertension of the newborn with the Score for Neonatal Acute Physiology-Version II (SNAP-II) in Thai neonates. J Perinat Med2011; 39: 311–315.
18.
FinerNN. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome. Paediatr Respir Rev2004; 5: S289–S297.
19.
BissingerRCarlsonCHulseyT. Secondary surfactant deficiency in neonates. J Perinatol2004; 24: 663–666.
20.
CelikIHDemirelGCanpolatFE. Surfactant therapy for maternal blood aspiration: an unusual cause of neonatal respiratory distress syndrome. Indian J Pediatr2012; 79: 1358–1359.
